Yizhe Wang - 11 May 2026 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Reporting relationship: Operating Partner
Issuer ticker: ZLAB
Reported as of: 11 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 16:29:53 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Bruce Blefeld, Attorney-in-Fact

Key filing fact

Yizhe Wang filed Form 4 for Zai Lab Ltd (ZLAB) on 08 Jun 2026.

Key facts

This page summarizes Yizhe Wang's Form 4 filing for Zai Lab Ltd (ZLAB).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Jun 2026, 16:29.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001884248 Primary reporting owner

Wang Yizhe

Relationship: Operating Partner
Address: C/O ZAI LAB LIMITED, 314 MAIN STREET, 4TH FLOOR, SUITE 100, CAMBRIDGE
Signature: /s/ Bruce Blefeld, Attorney-in-Fact
Signature date: 08 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZLAB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +136,819
Change %
Price: $0.000000^*
Shares after: 136,819
Date: 11 May 2026
Ownership: Direct
Underlying class: American Depositary Shares
Underlying amount: 136,819
Exercise price: $20.32
Footnotes: F1, F2

ZLAB transaction Derivative

Restricted Share Units

Award

Transaction value
Shares: +59,288
Change %
Price: $0.000000^*
Shares after: 59,288
Date: 11 May 2026
Ownership: Direct
Underlying class: American Depositary Shares
Underlying amount: 59,288
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.

Footnote F2

The option vests in equal annual installments over four years beginning on 05/11/2027, the first anniversary of the date of grant, subject to continuous service.

Footnote F3

Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS.

Footnote F4

The RSUs vest in equal annual installments over four years beginning on 05/11/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.